Purdue Pharma's Ultram Patents Deemed Invalid
A federal judge has ruled that two Purdue Pharma LP patents for painkiller Ultram ER are invalid, clearing the way for generic-drug maker Par Pharmaceuticals Inc. to make its own version...To view the full article, register now.
Already a subscriber? Click here to view full article